Dr. Mari DeMarco is a Clinical Chemist at St Paul's Hospital, and a Clinical Associate Professor in the Department of Pathology and Laboratory Medicine at the University of British Columbia in Vancouver Canada. Dr. DeMarco completed her PhD in the Biomolecular Structure and Design program at the University of Washington, and a clinical chemistry fellowship at Washington University School of Medicine.
Dr. DeMarco was named as a Michael Smith Foundation for Health Research Scholar for her research program developing and implementing diagnostic tests for Alzheimer’s disease and related forms of neurodegeneration. Her lab’s overall focus is on impacting patient care through the development of new and improved biofluid tests for peptide and protein biomarkers, and the translation of these tests into routine care. For example, Dr. DeMarco is the Principal Investigator of a Canada-wide study (IMPACT-AD) to investigate the impact of Alzheimer’s disease CSF biomarkers in routine care – using assays developed in her laboratory and validated for clinical use following FDA and Health Canada guidelines.